(Total Views: 204)
Posted On: 01/13/2020 6:27:13 AM
Post# of 36564
Related to mTNBC and indirectly NGIO as well as Regentys. CYDY, a company several of us have been following, today filed for BTD designation for its drug for the tx of certain types of breast cancer.
As of now the company is expecting to study 30 plus indications for the medicine, including inflammatory problem common in the bowel such as IBD and Crohn's.
I brought this company up a while back. Joe was at best lukewarm on the platform. Would have potentially been a great company to partner with considering the cancer and bowel synergies.
As of now the company is expecting to study 30 plus indications for the medicine, including inflammatory problem common in the bowel such as IBD and Crohn's.
I brought this company up a while back. Joe was at best lukewarm on the platform. Would have potentially been a great company to partner with considering the cancer and bowel synergies.
(0)
(0)
